BNP and NT-proBNP are blood tests that help show whether the heart is under pressure from excess stretch, fluid overload, or heart failure. They are especially useful when someone has shortness of breath, swelling, unexplained fatigue, or a sudden worsening of known heart disease. A low result can make heart failure less likely, while a high result can support the diagnosis and point toward higher risk. Still, these tests do not stand alone. Age, kidney function, atrial fibrillation, body weight, lung disease, and some heart medicines can all change the number.
The safest way to read BNP or NT-proBNP is to combine the result with symptoms, physical exam findings, an ECG, kidney tests, chest imaging when needed, and often an echocardiogram. The number is a signal, not a complete diagnosis.
- BNP and NT-proBNP rise when the heart muscle is stretched, often from high filling pressure or fluid overload.
- Low values are most useful for ruling out heart failure, especially BNP below 100 pg/mL or NT-proBNP below 300 pg/mL in acute shortness of breath.
- Chronic outpatient thresholds are lower: BNP below 35 pg/mL or NT-proBNP below 125 pg/mL makes heart failure less likely.
- High results can occur with heart failure, kidney disease, atrial fibrillation, pulmonary hypertension, older age, and severe infection.
- Obesity can lower BNP and NT-proBNP, so a “normal” result may be less reassuring in some people with clear symptoms.
- Severe breathlessness, chest pain, fainting, blue lips, or new confusion needs urgent care, regardless of the BNP or NT-proBNP number.
Table of Contents
- What BNP and NT-proBNP Measure
- Ranges and Cutoffs That Change by Setting
- Acute Symptoms vs Long-Term Heart Failure Checks
- Why BNP and NT-proBNP Levels Rise
- Why Results Can Mislead
- Other Tests That Add Context
- Using Trends Safely Over Time
- How to Respond to Your Result
What BNP and NT-proBNP Measure
BNP and NT-proBNP are natriuretic peptides, a group of hormones released mainly by the heart when its chambers are stretched. Stretch often happens when pressure or fluid builds up inside the heart. This can occur in heart failure, where the heart cannot fill, relax, or pump well enough to meet the body’s needs without increased pressure.
BNP stands for B-type natriuretic peptide. NT-proBNP stands for N-terminal pro-B-type natriuretic peptide. They come from the same parent molecule, proBNP. When proBNP is split, it produces active BNP and the inactive fragment NT-proBNP. Both can be measured in blood, and both give useful information about heart stress.
BNP has direct biological effects. It helps the body get rid of sodium and water, relaxes blood vessels, and counteracts some hormone systems that retain fluid. NT-proBNP does not have the same active hormone effect, but it stays in the blood longer, which makes it useful as a stable marker.
BNP and NT-proBNP are related, but they are not interchangeable. NT-proBNP values are usually much higher than BNP values, so the same number does not mean the same thing for both tests. A BNP of 300 pg/mL and an NT-proBNP of 300 pg/mL are not equivalent. For a deeper comparison of how the two markers differ, see BNP and NT-proBNP differences.
| Feature | BNP | NT-proBNP |
|---|---|---|
| What it is | Active hormone fragment | Inactive fragment from the same parent molecule |
| Typical blood level | Lower than NT-proBNP | Usually several times higher than BNP |
| Half-life | Shorter | Longer |
| Kidney effect | Can rise with reduced kidney function | Often rises more noticeably with reduced kidney function |
| Medicine effect | Can rise with neprilysin inhibitors such as sacubitril/valsartan | Preferred for monitoring when taking sacubitril/valsartan |
These tests do not measure a heart attack. They measure heart stretch and filling pressure more than direct heart muscle injury. A person can have a high BNP without a heart attack, and a person can have a heart attack with a BNP that is not yet very high. When the concern is injury to heart muscle cells, troponin is the more direct marker. BNP and troponin can both be useful, but they answer different questions.
The most common reason to order BNP or NT-proBNP is shortness of breath. In an emergency setting, the test helps separate heart failure from other causes such as asthma, chronic obstructive pulmonary disease, pneumonia, anemia, or anxiety-related breathing symptoms. In a clinic setting, it can help decide whether someone with ankle swelling, fatigue, reduced exercise tolerance, or persistent breathlessness needs an echocardiogram and cardiology evaluation.
Ranges and Cutoffs That Change by Setting
BNP and NT-proBNP cutoffs depend heavily on the clinical setting. The thresholds used for sudden severe shortness of breath are different from those used for slower outpatient symptoms. This is one of the main reasons people get confused when they compare results online.
In acute shortness of breath, clinicians often use BNP below 100 pg/mL or NT-proBNP below 300 pg/mL to make acute heart failure less likely. These rule-out cutoffs are designed to be sensitive. They help reduce the chance of missing heart failure when someone arrives with sudden breathlessness.
For chronic or outpatient symptoms, lower thresholds are often used. BNP below 35 pg/mL or NT-proBNP below 125 pg/mL makes chronic heart failure less likely. Values above these levels do not prove heart failure, but they often justify more evaluation, especially if symptoms fit.
| Situation | BNP | NT-proBNP | General Meaning |
|---|---|---|---|
| Acute shortness of breath | Below 100 pg/mL | Below 300 pg/mL | Acute heart failure is less likely |
| Chronic outpatient symptoms | Below 35 pg/mL | Below 125 pg/mL | Chronic heart failure is less likely |
| Acute symptoms with clearly high values | Often above 400–500 pg/mL | Often interpreted with age-adjusted cutoffs | Heart failure becomes more likely, but context still matters |
| Known heart failure follow-up | No universal “perfect” number | No universal “perfect” number | Trend, symptoms, kidney function, and treatment response matter most |
NT-proBNP is strongly affected by age, so age-adjusted interpretation is common in acute care. In adults with sudden breathlessness, higher NT-proBNP values are expected with older age even without the same degree of heart failure severity. Common acute rule-in ranges use about 450 pg/mL for people younger than 50, 900 pg/mL for ages 50–75, and 1,800 pg/mL for people older than 75. These are not “normal ranges” for healthy people. They are clinical decision points used in a specific setting.
BNP values are also influenced by age, but age-specific BNP cutoffs are less commonly emphasized than NT-proBNP cutoffs. For an individual result, always look at the lab’s reference interval and the reason the test was ordered. A value that is mildly high in a stable outpatient may mean something different from the same value in someone gasping for breath in the emergency department.
Many labs report BNP or NT-proBNP in pg/mL. Some systems use ng/L. For these markers, pg/mL and ng/L are numerically the same. For example, 300 pg/mL equals 300 ng/L.
The phrase “normal BNP” can also be misleading. Normal for ruling out acute heart failure, normal for a healthy reference population, and normal for someone with known stable heart failure are not the same idea. A person with treated heart failure may have a BNP or NT-proBNP above the lab range even when they are stable and doing well. The aim is not always to force the number into the reference range; it is to understand whether the person is congested, improving, worsening, or facing another problem.
Acute Symptoms vs Long-Term Heart Failure Checks
BNP and NT-proBNP are most powerful when the clinical question is clear. “Is this sudden shortness of breath from heart failure?” is a different question from “Is my known heart failure stable?” The same test can help with both, but the interpretation changes.
In acute care, BNP and NT-proBNP help sort out breathlessness quickly. Someone with fluid in the lungs, swollen legs, rapid weight gain, and a very high NT-proBNP likely needs urgent treatment for heart failure unless another explanation is stronger. Someone with wheezing, fever, a clear chest infection, and a low BNP may need treatment focused on the lungs or infection instead.
The test is especially helpful when symptoms overlap. Heart failure and lung disease can both cause breathlessness. Heart failure and kidney disease can both cause swelling. Heart failure and anemia can both cause fatigue. BNP and NT-proBNP add a heart-stress signal to the picture.
In long-term care, the tests help identify people who may need imaging, specialist review, or changes in treatment. A rising NT-proBNP in someone with known heart failure can suggest increasing pressure inside the heart before symptoms become dramatic. It may also reflect atrial fibrillation, worsening kidney function, infection, uncontrolled blood pressure, or missed medications.
BNP and NT-proBNP also help with heart failure with preserved ejection fraction, often called HFpEF. In HFpEF, the heart’s pumping percentage may look normal, but the heart can be stiff and fill under high pressure. This type of heart failure is common in older adults and in people with high blood pressure, obesity, diabetes, kidney disease, or atrial fibrillation. Natriuretic peptides can support the diagnosis, but HFpEF can be missed if the number is read too rigidly, especially in people with obesity.
Heart failure with reduced ejection fraction is often easier to confirm because the echocardiogram shows a reduced pumping percentage. In both reduced and preserved ejection fraction, BNP or NT-proBNP helps estimate cardiac stress and risk. It does not replace the echocardiogram, but it can help decide how urgent the echo is.
A single result should be matched to the story. Three people can have the same NT-proBNP and need different next steps:
- A 35-year-old with sudden breathlessness and NT-proBNP of 900 pg/mL needs serious evaluation.
- An 82-year-old with chronic kidney disease and stable symptoms may have the same value from several combined factors.
- A 70-year-old with known heart failure whose NT-proBNP rose from 900 to 3,000 pg/mL may be developing congestion even before severe swelling appears.
This is why the result should not be treated like cholesterol or glucose, where a single cutoff often carries clearer meaning. BNP and NT-proBNP are pressure-and-risk markers that behave differently across clinical situations.
Why BNP and NT-proBNP Levels Rise
BNP and NT-proBNP rise when the heart is stretched, but heart failure is not the only cause of stretch. A high value should prompt careful thinking rather than an automatic label.
The most common heart-related reason is increased filling pressure. The heart may be struggling to pump blood forward, relaxing poorly, or facing high pressure from stiff arteries, damaged valves, lung circulation problems, or rhythm disturbances. Fluid can then back up into the lungs, legs, abdomen, or liver.
Common heart-related causes of high BNP or NT-proBNP include:
- Heart failure with reduced ejection fraction
- Heart failure with preserved ejection fraction
- Atrial fibrillation or other rapid rhythm problems
- Pulmonary hypertension
- Significant valve disease, such as aortic stenosis or mitral regurgitation
- Right-sided heart strain from lung disease or pulmonary embolism
- Recent heart attack or myocarditis
- Severe uncontrolled blood pressure
A high result can also reflect non-heart factors that place stress on the circulation. Kidney disease is a major one. When kidney function falls, NT-proBNP often rises because clearance is reduced and because kidney disease commonly travels with high blood pressure, volume overload, and heart structure changes. BNP can rise too, though NT-proBNP is often more affected. When kidney function is part of the question, creatinine and eGFR help show whether reduced filtration may be contributing to the number.
Severe infections, sepsis, anemia, thyroid disease, stroke, and major surgery can also raise BNP or NT-proBNP. These conditions increase strain on the heart even if the person does not have chronic heart failure.
| Cause | Why It Can Raise the Marker | Clue That Helps Interpretation |
|---|---|---|
| Heart failure | High filling pressure stretches the heart chambers | Shortness of breath, swelling, rapid weight gain, abnormal echo |
| Atrial fibrillation | Irregular rhythm increases atrial and ventricular stress | Palpitations, irregular pulse, ECG findings |
| Kidney disease | Reduced clearance and fluid overload can raise levels | High creatinine, low eGFR, abnormal urine findings |
| Pulmonary hypertension or lung strain | The right side of the heart works against higher pressure | Low oxygen, lung disease, echo signs of right-heart strain |
| Older age | Heart stiffness, kidney changes, and vascular changes become more common | Interpret NT-proBNP with age in mind |
| Severe infection or critical illness | Inflammation and circulation stress increase cardiac workload | Fever, low blood pressure, high inflammatory markers |
A high BNP or NT-proBNP does carry risk information. In general, higher levels are linked with higher chances of hospitalization, complications, and death in people with heart failure. This does not mean the number predicts exactly what will happen to one person. It means clinicians should take a clearly elevated or rising result seriously, especially when symptoms are changing.
Why Results Can Mislead
BNP and NT-proBNP are useful because they are sensitive to heart stress. That same sensitivity makes them imperfect. Several common situations can make the result look higher or lower than expected.
Obesity can suppress BNP and NT-proBNP. A person with a higher body mass index may have lower natriuretic peptide levels than a lean person with the same degree of heart failure. The reason is not only dilution from body size; hormonal and metabolic factors also appear to affect peptide production and clearance. This is important because many people with HFpEF also have obesity. A low result lowers the chance of heart failure, but it does not erase strong symptoms, abnormal exam findings, or concerning echo results.
Atrial fibrillation can raise BNP and NT-proBNP even without classic fluid overload. The upper chambers of the heart are under electrical and mechanical stress during atrial fibrillation, and that stress can push levels upward. In someone with both atrial fibrillation and breathlessness, a high result may reflect rhythm, heart failure, or both.
Kidney disease can raise results, especially NT-proBNP. This does not make the test useless. It means the cutoff should not be read in isolation. A very high NT-proBNP in advanced kidney disease may still signal serious heart strain, but the expected baseline may be higher.
Medicines can also matter. Sacubitril/valsartan is an angiotensin receptor-neprilysin inhibitor used in heart failure. Because neprilysin helps break down BNP, this medicine can raise BNP levels or make BNP harder to interpret after treatment starts. NT-proBNP is generally preferred for follow-up in people taking this medication because it is not directly increased by neprilysin inhibition.
Very early symptoms may not always produce a dramatic rise right away. A person with sudden chest pain, fainting, severe breathlessness, or signs of shock should not be reassured by a single marker that does not fit the situation. Lab tests support clinical judgment; they do not replace it.
Lab-to-lab differences also exist. BNP and NT-proBNP assays are standardized well enough for clinical use, but different platforms can produce somewhat different values. For trend monitoring, it is best to compare results from the same lab or at least the same test type whenever possible.
Common mistakes include:
- Comparing BNP directly with NT-proBNP as if the numbers were interchangeable
- Calling every high result “heart failure” without checking kidney function, rhythm, age, and symptoms
- Ignoring heart failure symptoms because the result is only mildly elevated
- Overreacting to a stable chronic elevation in someone already diagnosed and treated
- Tracking tiny changes that fall within normal biological and lab variation
- Using BNP for treatment monitoring after starting sacubitril/valsartan when NT-proBNP would be clearer
A result should make sense next to the person in front of the clinician. Mild ankle swelling after a salty meal, a borderline BNP, normal oxygen, and a normal exam are different from severe breathlessness, crackles in the lungs, low oxygen, and a rapidly rising NT-proBNP.
Other Tests That Add Context
BNP and NT-proBNP are usually part of a larger evaluation. The next tests depend on symptoms, urgency, and medical history, but several are especially common.
An echocardiogram is often the most important follow-up test when heart failure is suspected. It uses ultrasound to show heart structure, pumping function, valve disease, chamber size, wall thickness, estimated lung pressures, and signs of stiffness or high filling pressure. BNP or NT-proBNP can suggest heart failure; the echocardiogram helps explain the type and likely cause.
An ECG checks heart rhythm, conduction, prior heart attack patterns, and signs of strain. It can detect atrial fibrillation, rapid rhythms, slow rhythms, and other electrical problems that may raise natriuretic peptides or cause symptoms.
Kidney blood tests and electrolytes are essential because kidney function affects fluid balance and NT-proBNP levels. Sodium, potassium, bicarbonate, BUN, creatinine, and eGFR can change the interpretation and treatment plan. In someone taking diuretics, ACE inhibitors, ARBs, mineralocorticoid receptor antagonists, or sacubitril/valsartan, potassium and kidney function need especially close attention. The pattern of potassium and creatinine can influence whether medicines are safe to start, increase, hold, or adjust.
Troponin may be ordered when chest pain, ECG changes, sudden severe symptoms, or possible heart attack is part of the picture. Troponin detects heart muscle injury, while BNP and NT-proBNP reflect stretch and pressure. A person with heart failure can have mildly elevated troponin from strain, and a person with a heart attack can have rising BNP if the event causes pump failure. The relationship between troponin and BNP is helpful when symptoms could involve both injury and overload.
Chest X-ray or lung ultrasound can show fluid in the lungs, pneumonia, enlarged heart size, or other causes of breathlessness. Oxygen level, blood count, thyroid testing, liver tests, and inflammatory markers may also help when the story is unclear.
No single test carries the whole diagnosis. A strong evaluation asks:
- Are symptoms consistent with heart failure?
- Is there objective evidence of congestion or high filling pressure?
- Does imaging support reduced pumping, stiffness, valve disease, or right-heart strain?
- Are kidney disease, rhythm problems, infection, anemia, or lung disease contributing?
- Is this new heart failure, worsening known heart failure, or another condition mimicking it?
BNP and NT-proBNP work best when they trigger the right next question.
Using Trends Safely Over Time
Trends can be more useful than isolated numbers, especially in people with known heart failure. A falling NT-proBNP after treatment often suggests reduced heart stress and better fluid status. A rising level can signal worsening congestion, missed medications, uncontrolled blood pressure, new atrial fibrillation, kidney decline, infection, or another new stressor.
Still, chasing a perfect number can lead to overtreatment. Diuretics, for example, can relieve congestion, but too much diuresis can cause dehydration, low blood pressure, kidney injury, dizziness, and electrolyte problems. The aim is not simply to lower BNP or NT-proBNP at any cost. The aim is better breathing, less congestion, safer kidney function, stable blood pressure, and fewer hospitalizations.
Small changes are less useful than clear patterns. A BNP change from 180 to 210 pg/mL may not mean much by itself. A change from 500 to 1,800 pg/mL with new swelling and shortness of breath is more concerning. NT-proBNP often has larger numerical swings, so the size of the change should be judged against baseline and symptoms.
For known heart failure, it helps to know the person’s “stable range.” Some people feel well and remain stable with values above the lab reference range. Others usually have low values, so a moderate rise may be meaningful. The more useful comparison is often today’s result against that person’s prior results, not against a generic cutoff.
Timing matters too. BNP and NT-proBNP can change during hospitalization, after diuretic treatment, after starting guideline-directed medicines, or after recovery from infection. A result taken during a crisis should not be treated as the person’s usual baseline. A follow-up value after recovery can be more informative.
Testing too often can create noise. In stable outpatients, repeat testing is usually most helpful when symptoms change, medications are being adjusted, risk is being reassessed, or the clinician is trying to clarify whether breathlessness is cardiac. Daily or very frequent checks outside the hospital rarely help unless there is a specific reason.
For people using home monitoring, weight and symptoms remain important. A rapid weight gain of 2–3 pounds in 24 hours or 5 pounds in a week can suggest fluid retention in many heart failure plans, though personal thresholds vary. New breathlessness when lying flat, waking up gasping, swelling, reduced urine after diuretics, or needing more pillows can matter as much as a lab value.
How to Respond to Your Result
The right response depends on the number, the symptoms, and the setting. A BNP or NT-proBNP result should be read with the clinician who ordered it, but some general patterns can help you understand the next step.
A low result during sudden shortness of breath makes acute heart failure less likely. It does not automatically diagnose the true cause. The next step may be evaluation for lung disease, infection, anemia, blood clot, medication side effects, anxiety, or another cause.
A mildly elevated result in a stable outpatient often calls for context rather than panic. Age, kidney function, atrial fibrillation, body weight, and blood pressure can all contribute. If symptoms are present, an echocardiogram may be appropriate. If there are no symptoms, the result may still identify higher future cardiovascular risk, but it should not be treated as heart failure by itself.
A clearly high result with breathlessness, swelling, rapid weight gain, or reduced exercise tolerance deserves prompt medical review. The clinician may check oxygen level, exam findings, ECG, kidney function, electrolytes, chest imaging, and echocardiography. Treatment may include diuretics to remove excess fluid and heart failure medications that improve outcomes when indicated.
A rapidly rising result in known heart failure should be taken seriously, especially if symptoms are worse. It may mean fluid is building before it becomes obvious. It may also reflect a new rhythm problem, infection, kidney decline, or medication issue. Do not adjust diuretics or heart medicines on your own unless you already have a written plan from your clinician.
Seek urgent care now if BNP or NT-proBNP is high and any of these are present:
- Severe shortness of breath at rest
- Chest pain, pressure, or pain spreading to the jaw, back, shoulder, or arm
- Fainting, near-fainting, or new confusion
- Blue lips, very low oxygen, or extreme weakness
- Coughing pink or frothy sputum
- New rapid or irregular heartbeat with breathlessness or dizziness
- Sudden swelling with inability to lie flat
- Very low blood pressure or signs of shock
Prepare for a follow-up visit by bringing the result, the test date, your symptoms, your weight trend, your blood pressure readings if available, and a full medication list. Mention whether you take diuretics, sacubitril/valsartan, blood pressure medicines, diabetes medicines, anti-inflammatory drugs such as ibuprofen or naproxen, or heart rhythm medicines.
A useful question is not “Is my BNP bad?” A better question is: “Does this result fit heart failure, and what evidence supports that?” The answer may involve an echo, kidney tests, rhythm review, and symptom pattern. The number is valuable, but the person’s breathing, fluid status, rhythm, kidney function, and heart structure complete the picture.
References
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure 2022 (Guideline)
- 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee 2023 (Expert Consensus)
- 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2023 (Guideline)
- Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society 2023 (Position Statement)
- Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure 2022 (Review)
- Guideline for the Use of Natriuretic Peptides in the Early Diagnosis of Heart Failure in Primary Care 2025 (Guideline)
Disclaimer
BNP and NT-proBNP results should be interpreted by a qualified clinician who can review symptoms, exam findings, kidney function, rhythm, medicines, and imaging. A high result does not prove heart failure by itself, and a low result should not be used to ignore severe or worsening symptoms. Seek urgent medical care for severe breathlessness, chest pain, fainting, confusion, blue lips, or rapidly worsening swelling.
